← Open Payments lookup

ALISHA MOORE: Open Payments

NPI 1710407150 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$588 in 32 payments from 14 companies in 2025. Trend: 2023 $661 · 2024 $547 · 2025 $588

Food & beverage: $588
CompanyPaymentsAmount
Novo Nordisk Inc12$182
Dexcom, Inc.5$102
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$46
Abbott Laboratories2$41
Vanda Pharmaceuticals Inc.1$37
Bayer Healthcare Pharmaceuticals Inc.2$32
Otsuka America Pharmaceutical, Inc.1$27
Novartis Pharmaceuticals Corporation1$21
Lundbeck LLC1$20
GlaxoSmithKline, LLC.1$20

Products named: Wegovy, Dexcom G6 Transmitter, REXULTI, CAPLYTA, Ozempic, FREESTYLE LIBRE 3, FANAPT, Kerendia.

Industry payments across AL — which companies pay providers there.